Physician profile
David Bock
NPI 1386693026
$5,650.93
in general payments reported to CMS, 2019-2025
39 companies · $828 in 2025
The $828 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,640 · 2020: $461 · 2021: $346 · 2022: $490 · 2023: $428 · 2024: $1,459 · 2025: $828.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,761 · Travel and Lodging: $954.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,761.23 |
| Travel and Lodging | $953.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $987.87 | 2023-2024 | Nanoknife |
| Janssen Biotech, INC. | $934.97 | 2019-2024 | Erleada |
| Dendreon Pharmaceuticals LLC | $516.40 | 2019-2023 | Provenge |
| Bayer Healthcare Pharmaceuticals INC. | $421.81 | 2019-2025 | |
| Astellas Pharma US INC | $388.38 | 2019-2024 | Veozah |
| Histosonics, INC. | $297.44 | 2025 | |
| Novartis Pharmaceuticals Corporation | $271.13 | 2023-2025 | |
| Abbvie INC. | $246.15 | 2019-2025 | Lupron Depot |
| Pfizer INC. | $237.72 | 2019-2024 | |
| Progenics Pharmaceuticals, INC. | $179.12 | 2023-2025 | Pylarify |
| Teleflex LLC | $134.52 | 2024-2025 | Barrigel |
| Urogen Pharma, INC. | $98.79 | 2024-2025 | |
| Coloplast Corp | $84.93 | 2019-2024 | |
| Amgen INC. | $75.93 | 2019-2020 | |
| Immunitybio, INC. | $68.97 | 2025 |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $63.13 | 2023 | Adstiladrin |
| Profound Medical Corp. | $58.10 | 2022 | |
| Allergan, INC. | $54.39 | 2019-2020 | |
| Agiliti Health, INC. | $52.14 | 2024-2025 | Sonablate Hifu, Siemens Healthineer Varian Intelliblate Microwave Ablation, Koelis Trinity Mri/US Fusion |
| Blue Earth Diagnostics | $45.09 | 2019-2020 | |
| Innovation Technologies INC | $39.41 | 2022 | |
| Boston Scientific Corporation | $38.25 | 2019-2025 | Spaceoar System |
| Convatec INC. | $38.23 | 2020-2022 | |
| Ambu INC. | $34.60 | 2021-2024 | |
| Olympus America INC. | $31.64 | 2021-2022 | |
| Urovant Sciences INC | $26.60 | 2021-2022 | |
| Tempus Ai, INC | $24.53 | 2024 | |
| Rochester Medical Corporation | $24.40 | 2022 | |
| Myriad Genetic Laboratories, INC. | $24.17 | 2020-2021 | |
| Antares Pharma, INC. | $19.48 | 2022 | |
| Civco Medical Instruments | $19.02 | 2025 | |
| Sun Pharmaceutical Industries INC. | $17.59 | 2019 | |
| Axonics, INC. | $16.83 | 2020 | |
| Eisai INC. | $15.64 | 2025 | |
| Baudax Bio INC. | $14.52 | 2021 | |
| Zyla Life Sciences, INC. | $12.89 | 2019 | |
| Therapeuticsmd, INC. | $12.37 | 2019 | |
| Endo Pharmaceuticals INC. | $12.05 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $11.73 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Bock listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.